Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 12 citing articles:

Current landscape of fecal microbiota transplantation in treating depression
Qi Zhang, Yajun Bi, Boyu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
TMEM132C and LIPE protein molecules drive synovial hyperplasia via the PPARγ signaling axis: Mechanistic insights into core pathogenic proteins in rheumatoid arthritis
Fangyue Cheng, Zhen Dai, Jinling Zhang
International Journal of Biological Macromolecules (2025), pp. 143027-143027
Closed Access
Integrative analysis of signaling and metabolic pathways, immune infiltration patterns, and machine learning-based diagnostic model construction in major depressive disorder
Lei Tang, Li‐Ling Wu, Mengqin Dai, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
QbD‐Based Fabrication of Biomimetic Hydroxyapatite Embedded Gelatin Nanoparticles for Localized Drug Delivery against Deteriorated Arthritic Joint Architecture
Qurat Ul Ain, Mahira Zeeshan, Danish Mazhar, et al.
Macromolecular Bioscience (2023) Vol. 24, Iss. 2
Open Access | Times Cited: 8
Integrative Analyses of Bulk and Single-Cell RNA Seq Identified the Shared Genes in Acute Respiratory Distress Syndrome and Rheumatoid Arthritis
Jun Shi, Jiajia Tang, Lu Liu, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 2
Bioinformatics analysis of the potential receptor and therapeutic drugs for Alzheimer’s disease with comorbid Parkinson’s disease
Xue‐Rong Zhou, Z X Liu, Guiqin Bai, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 2
Analysis of potential diagnostic markers and therapeutic targets for Rheumatoid Arthritis with comorbid Depression immunologic indicators
Tiantian Fu, Yiran Liu, Haozhi Jia, et al.
Behavioural Brain Research (2024) Vol. 471, pp. 115098-115098
Closed Access | Times Cited: 2
The Depression Prevalence in Chinese Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis.
Jiawei Huang, Wenyuan Chen, Peijun Zhu
PubMed (2023) Vol. 51, Iss. 6, pp. 271-280
Closed Access | Times Cited: 4
Mining key circadian biomarkers for major depressive disorder by integrating bioinformatics and machine learning
Yuhe Shi, Jue Zhu, Chaowen Hou, et al.
Aging (2024) Vol. 16, Iss. 12, pp. 10299-10320
Open Access
Causal-inferring and molecular-docking yield new targets for malignant melanoma therapy
Yan Jin, Xia Ding, Chunyuan Xu
Archives of Dermatological Research (2024) Vol. 317, Iss. 1
Closed Access
Viewpoint: Could better understanding of risk factors for comorbidities pave the way towards personalized therapy in rheumatoid arthritis?
Judit Majnik, György Nagy
Lara D. Veeken (2023) Vol. 62, Iss. SI3, pp. SI271-SI273
Open Access | Times Cited: 1
Limosilactobacillus-related 3-OMDP as a potential therapeutic target for depression
Qi Zhong, Wentao Wu, Jing Xie, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access
Page 1

Scroll to top